Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy

Maxime W.C. Rousseaux(University of Ottawa), Scott D. Ryan(Scintillon Institute)
Research Square
August 17, 2023
10.21203/rs.3.rs-3182457/v1
Cited by 1

Related Papers

A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1
|eLife|2015|45
Characterizing the differential distribution and targets of Sumo1 and Sumo2 in the mouse brain
|iScience|2023|12
Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
|Cell Death and Disease|2024|6
Characterizing the differential distribution and targets of Sumo paralogs in the mouse brain
|bioRxiv (Cold Spring Harbor Laboratory)|2022|2
Author response: A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1
|Unknown|2015|1